Fragment-Based Drug Discovery
From Proteopedia
(Difference between revisions)
| Line 36: | Line 36: | ||
| align="center" | <scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Ala108</scene> || align="center" | <scene name='Sandbox_reserved_394/Tyrosine_105/1'>Tyr105</scene> || align="center" | <scene name='Sandbox_reserved_394/Phe_101/1'>Phe101</scene> || align="center" | <scene name='Sandbox_reserved_394/Glycine_142/1'>Gly142</scene> | | align="center" | <scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Ala108</scene> || align="center" | <scene name='Sandbox_reserved_394/Tyrosine_105/1'>Tyr105</scene> || align="center" | <scene name='Sandbox_reserved_394/Phe_101/1'>Phe101</scene> || align="center" | <scene name='Sandbox_reserved_394/Glycine_142/1'>Gly142</scene> | ||
|} | |} | ||
| - | + | </StructureSection> | |
=== ABT-737 === | === ABT-737 === | ||
| Line 53: | Line 53: | ||
| - | + | ||
== References == | == References == | ||
{{Reflist}} | {{Reflist}} | ||
Revision as of 18:27, 3 October 2012
Apoptosis by Inhibition of Bcl-2 Family Proteins
| |||||||||||
ABT-737
Using this acylsulfonamide-based ligand as a template, or pharmacophore, other drugs can be designed to have similar effects. has been shown to effectively inhibit the over-expression of this protein thereby inducing tumor regression and increasing chemo-sensitivity.
References
- ↑ Oltersdorf T., Elmore S.W., Shoemaker A.R. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Vol 435|2 June 2005|doi:10.1038/nature03579
